Article

Somatic Mutation Profiling by NGS-Based Liquid Biopsy in Advanced Non- Small Cell Lung Cancer: Frequency, Clinical Correlates, and Prognostic Significance

2026-05-04

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Liquid biopsy-based next-generation sequencing (NGS) enables non-invasive, comprehensive mutational profiling in advanced non-small cell lung cancer (NSCLC). However, data on multi-gene cfDNA panels in Turkish populations remain limited. <bold>Methods:</bold> One hundred consecutive stage IV NSCLC patients (42 newly diagnosed, 58 with progression/recurrence...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 68148161-2c53-565f-8084-da2a80b1dcc5
DOI: 10.21203/rs.3.rs-9396662/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Somatic Mutation Profiling by NGS-Based Liquid Biopsy in Advanced Non- Small Cell Lung Cancer: Frequency, Clinical Correlates, and Prognostic SignificanceDOI 10.21203/rs.3.rs-9396662/v1Read

Somatic mutation profiling by NGS-based liquid biopsy in advanced non-small cell lung cancer: frequency, clinical correlates, and prognostic significance.Semantic proximity Read

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.Semantic proximity Read

Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) PatientsSemantic proximity Read

Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer.Semantic proximity Read

Mutation profile of non-small cell lung cancer revealed by next generation sequencingSemantic proximity Read

Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare HospitalSemantic proximity Read

Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system.Semantic proximity Read

Plasma-based longitudinal mutation monitoring as a potential predictor of disease progression in subjects with adenocarcinoma in advanced non-small cell lung cancer.Semantic proximity Read

Recent advance of next-generation sequencing in patients with lung cancer.Semantic proximity Read

KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal settingSemantic proximity Read

Next-Generation Sequencing in Lung Cancers-A Single-Center Experience in Taiwan.Semantic proximity Read

Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patientsSemantic proximity Read